Search   
MSDS  : Amine curing agent, XH 713-50
CAS  : 597-40-0
SYNONYMS  : * XH 173-50
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : BF2655000
CHEMICAL NAME : Amine curing agent, XH 713-50
LAST UPDATED : 198611
DATA ITEMS CITED : 4
COMPOUND DESCRIPTOR : Primary Irritant
SYNONYMS/TRADE NAMES :
* XH 173-50

*** HEALTH HAZARD DATA ***

** SKIN/EYE IRRITATION DATA **

TYPE OF TEST : Standard Draize test
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 10 mg/24H
REACTION SEVERITY : Mild
REFERENCE :
AMIHAB AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60.
For publisher information, see AEHLAU. Volume(issue)/page/year: 20,390,1959

TYPE OF TEST : Standard Draize test
ROUTE OF EXPOSURE : Administration into the eye
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 100 mg
REACTION SEVERITY : Moderate
REFERENCE :
AMIHAB AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60.
For publisher information, see AEHLAU. Volume(issue)/page/year: 20,390,1959

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3430 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AMIHAB AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60.
For publisher information, see AEHLAU. Volume(issue)/page/year: 20,390,1959

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 1130 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AMIHAB AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60.
For publisher information, see AEHLAU. Volume(issue)/page/year: 20,390,1959

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Amine curing agent, CD 16005 597-40-0
Amine curing agent, CD 16009 597-40-0
Amine curing agent, CD 16018 A 597-40-0
Amine curing agent, CD 16019 A 597-40-0
Amine curing agent, XH 713-50 597-40-0
Amines, C(sub 18-20)-tert-alkyl 69225-84-9
Amines, C10-18-alkyl, hydrochlorides 80448-80-2
Albumin, egg 9006-59-1
Amines, N-C12-18-alkyltrimethylenedi- 68155-37-3
Amines, coco alkyl, benzoates 68526-65-8
Amines, N-coco alkyltrimethylenedi- 61791-63-7
Amines, N-coco alkyltrimethylenedi-, acetates 61791-64-8
Amines, N-coco alkyltrimethylenedi-, adipates 68155-42-0
Amines, N-coco alkyltrimethylenedi-, benzoates 68188-29-4
Amines, N-coco alkyltrimethylenedi-, glycolates 68155-43-1
Amines, hydrogenated tallow alkyl, acetates 61790-59-8
Amines, N-soya alkyltrimethylenedi- 61791-67-1
Amines, tallow alkyl, acetates 61790-60-1
Albumin, from grape seed 61790-60-1
Amines, N-tallow alkyltrimethylenedi-, diacetates 68911-78-4
Amines, tri-C(sub 8-10)-alkyl- 68814-95-9
Amino acid granule for heptic encephalopathy, MHS-G 68814-95-9
Amino acids, BCAA-GSUBSTANCE DEFINITION :Consists of 3 branched amino acids, L-isoleucine, L-leucine and L-valineREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-Volume(issue)/page/year: 23,1843,1989 68814-95-9
Amino acid solution, ED-AC 68814-95-9
Amino acid solution for patients with hepaticencephalopathy, MHS-2 68814-95-9
Amino acid solution for renal failure, MRX-III 68814-95-9
Amino acid for renal insufficinecy, AMI-U-II 68814-95-9
Amino acid solution for renal insufficiency, TO-70 68814-95-9
Amino acid solution, Ispol 68814-95-9
Albumin, human serum sonicated 68814-95-9
Amino acid solution, Moriamin 68814-95-9
Amino acid solution, Moriamin-S 68814-95-9
Amino acids solution, MPR-F 65072-01-7
Amino acids solution, P-1 65072-01-7
Amino acid solution, TA 7.2 65072-01-7
Amino acid solution, TAT-7180H 65072-01-7
Amino acid solution, TAT-7180L 65072-01-7
Amino acids solution, CNT(H) 65072-01-7
Amino acids solution, CNT(L) 65072-01-7
Amino acids solution, CSH 65072-01-7
Albumin, pyrolyzate 65072-01-7
Amino acids solution, GA-1080(H) 65072-01-7
Amino acids solution, GM-1 65072-01-7
Amino acids solution, GM-2 65072-01-7
Amino acids solution, TAB-1 65072-01-7
Amino acids solution, TAB-2 65072-01-7
Aminoacylase 9012-37-7
alpha-Aminoimidazole-4-propionic acid, cobalt(2+)salt 14873-10-0
Amipramine, hydrochloride 14873-10-0
Amipurimycin, hydrateSUBSTANCE DEFINITION :Isolated from culture filtrate of Streptomyces novoguineesis T-36496REFERENCE :JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- 14873-10-0

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net